載入...
Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy
INTRODUCTION: Gaucher disease is the first lysosomal disease to benefit from enzyme replacement therapy, thus serving as model for numerous other lysosomal diseases. Alglucerase was the first glucocerebrosidase purified from placental extracts, and this was then replaced by imiglucerase – a Chinese...
Na minha lista:
| 發表在: | Core Evid |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5072572/ https://ncbi.nlm.nih.gov/pubmed/27790078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S93717 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|